Aarti Pharmalabs Ltd.
Snapshot View

View in App

Prices View details >>

275.00 -4.15 ▼-1.5%

31 March 2023, 04:01:00 PM
Volume: 24,768

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Market Cap 2,489.04 Cr.
Enterprise Value(EV) 2,744.39 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 13.49 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 20.39 Trailing Twelve Months Ending 2022-03
Industry PE 32.41 Trailing Twelve Months Ending 2022-03
Book Value / Share 152.96 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.80 Calculated using Price: 275.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 9.06 Cr. 90,626,008 Shares
FaceValue 5
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.49%
1 Week
-4.08%
1 Month
-9.27%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

2 years 2021-03 2022-03
Return on Equity (%) -2.02 18.23
Return on Capital Employed (%) -1.87 19.40
Return on Assets (%) -1.84 11.98

Balance Sheet View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 0 1,386
Non Curr. Liab. 73
Curr. Liab. 0 581
Minority Int.
Equity & Liab. 0 2,040
Non Curr. Assets 1,012
Curr. Assets 0 1,028
Misc. Exp. not W/O
Total Assets 0 2,040

Profit Loss View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 1,200
Other Income 4
Total Income 1,204
Total Expenditure -995
PBIDT 209
Interest -12
Depreciation -42
Taxation -33
Exceptional Items
PAT 122
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 122
Adjusted EPS 0 4,890

Cash Flow View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -44
Cash Fr. Inv. -139
Cash Fr. Finan. 260
Net Change 78
Cash & Cash Eqvt 0 83

Shareholding Pattern View Details >>

No shareholding pattern found.

Announcements View Details >>

Wed, 29 Mar 2023
Closure of Trading Window
Intimation of Closure of Trading Window.
Fri, 03 Mar 2023
Announcement under Regulation 30 (LODR)-Credit Rating
Intimation regarding Credit rating
Tue, 14 Feb 2023
Financial Statements For The Nine Months Ended December 31 2022
Financial Statements for the nine months ended December 31 2022

Technical Scans View Details >>

Fri, 31 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing 52 Week Low Close Crossing 52 Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Aarti Pharmalabs Ltd.

What is Aarti Pharmalabs share price?
Can I buy Aarti Pharmalabs shares now?
What is the Market Cap of Aarti Pharmalabs?
What are the key metrics to analyse Aarti Pharmalabs?
What is the 52 Week High and Low of Aarti Pharmalabs?
What is the trend of Aarti Pharmalabs share price?